Month: June 2022

Aria Study did not achieve statistical significance on the primary endpoint Strategic realignment to focus resources on Movement Disorders and Epilepsy franchises extends cash runway into 2024 BOSTON, June 06, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that the Phase 2/3 Aria Study evaluating the efficacy and safety of PRAX-114 for monotherapy treatment of major depressive disorder (MDD) did not achieve statistical significance on the primary endpoint of change from baseline in the 17-item Hamilton Depression Rating Scale (HAM-D17) total score at Day 15, or on any secondary endpoints....

BOSTON, June 06, 2022 (GLOBE NEWSWIRE) — ARIA Cybersecurity Solutions, a CSPi business (NASDAQ: CSPi) announces its ARIA Zero Trust Gateway, a next-generation network security solution focused on automated 100G Network Response accelerated by the NVIDIA® BlueField-2® DPU.  Network Service Providers and Cloud Operators asked for a better approach than a firewall/IPS to solve today’s network security requirements. They need to stop a wider array of network attacks immediately, as soon as detected, at today’s 100G network line rates.  Key capabilities of the solution include: Runs in-line at 100G as well as 10 and 25 G speeds Finds and stops network attacks and data exfiltration in real-time  Runs fully automated  Does not impact customer data performance or service SLAs  Lowers the cost per protected packet by up to 10x  Lowers...

ZURICH, Switzerland, June 06, 2022 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and its annual financial statements for the year 2021 on June 10, 2022 at the latest. As a company listed on SIX, Achiko is required to publish its annual report, together with the annual financial statements, within four months of the balance sheet date. Due to the Covid-19 pandemic, new staffing, and training under difficult conditions in consequence of measures taken by several countries required a lot of management capacity. As a result, the publication of the annual report 2021, together with the annual financial statements and the audit report, will occur in the month of June 2022. Achiko has...

Foresight Enterprise VCT plcLEI: 213800MWJNR3WZZ3ZP42 NAV Announcement The Board of Foresight Enterprise VCT plc announces that the Net Asset Value as at 31 March 2022 was 70.8p per share. For further information please contact:Gary Fraser, Foresight Group: 020 3667 8181

Trial will evaluate AB-729, an RNAi therapy in combination with VTP-300, an immunotherapeutic, and NA therapy WARMINSTER, Pa. and OXFORD, United Kingdom, June 06, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, and Vaccitech plc (Nasdaq: VACC), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines, today announced the first patient dosed in a Phase 2a clinical trial. This trial will evaluate Arbutus’ RNAi therapeutic candidate, AB-729, in combination with Vaccitech’s T-cell stimulating immunotherapeutic, VTP-300, and standard-of-care nucleos(t)ide reverse transcriptase inhibitor (NA) therapy...

HOUSTON, June 06, 2022 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that that CEO Dave Holeman, will participate in a “Fireside Chat” at NAREIT’s 2022 REITweek. Mr. Holeman will be hosted by JMP Securities Analyst Mitch Germain. When: Wednesday, June 8, 2022 at 7:00 Central / 8:00 EasternLink to Audio: https://ir.whitestonereit.com/corporate-profile/default.aspx A replay will be available after the event utilizing the link above. About Whitestone REIT Whitestone REIT (NYSE: WSR) is a community-centered real estate investment trust (REIT) that acquires, owns, operates, and develops open-air, retail centers located in some of the fastest growing markets in the country:  Phoenix, Austin, Dallas-Fort Worth, Houston and San Antonio.  Our centers are convenience focused: merchandised...

Uudenkaupungin kaupunki Pörssitiedote 6.6.2022 klo 14:00 Uudenkaupungin kaupunki on jättänyt hakemuksen alla mainitun arvopaperinsa (joukkovelkakirjalaina) ottamiseksi kaupankäynnin kohteeksi säännellylle markkinalle.  Lainan nimi: City of Uusikaupunki Notes EUR 28.000.000 2/2022 ISIN-koodi: FI4000517826Lainan määrä: 28.000.000 EUR Laina laskettiin liikkeeseen 08.02.2022. Danske Bank toimi joukkovelkakirjalainan liikkeeseenlaskun pääjärjestäjänä. Lisätietoja antaa: Uudenkaupungin kaupunki Anne Takala Puh. +358 (0)500 757 657, anne.takala@uusikaupunki.fiwww.uusikaupunki.fi 

PRESS RELEASE Immunocore presents new data on KIMMTRAK (tebentafusp-tebn) in metastatic cutaneous (mCM) and uveal melanoma (mUM) at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Tebentafusp and anti-PDL1 show 1 year overall survival (OS) of approximately 75% in heavily pre-treated mCM compared to benchmark of 55% Characterization of safety and efficacy in patients treated with tebentafusp beyond progression Corticosteroid use for treating adverse events of T cell engagers has no significant impact on efficacy (OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & ROCKVILLE, Md., US, 6 June 2022) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed...